Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Orthop. Dec 18, 2024; 15(12): 1155-1163
Published online Dec 18, 2024. doi: 10.5312/wjo.v15.i12.1155
Table 4 Multivariate analysis of overall survival in patients with bone metastasis of gene mutation-negative non-small cell lung cancer

Characteristic
HR
95%CI
P value
Use of ICIs after bone metastasis diagnosisYes0.350.14–0.860.023
Use of bone-modifying agent after bone metastasis diagnosisYes0.430.16–1.20.12
ECOG PS≤ 10.50.20–1.30.14